UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer

European urology, 2018-07, Vol.74 (1), p.57-62

2018

Volltextzugriff (PDF)

Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?

BMC cancer, 2020-01, Vol.20 (1), p.34-34, Article 34

2020

Volltextzugriff (PDF)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Radiation oncology (London, England), 2017-10, Vol.12 (1), p.163-163, Article 163

2017

Volltextzugriff (PDF)

Next‐generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage—Multicenter experience

Head & neck, 2020-04, Vol.42 (4), p.599-607

2020

Volltextzugriff (PDF)

Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System

Frontiers in pharmacology, 2021-10, Vol.12, p.754390-754390

2021

Volltextzugriff (PDF)

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study

PloS one, 2016-09, Vol.11 (9), p.e0162813-e0162813

2016

Volltextzugriff (PDF)

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer

PloS one, 2016-07, Vol.11 (7), p.e0157548

2016

Volltextzugriff (PDF)

Media representations of national and international standardized testing in the Israeli education system

Discourse (Abingdon, England), 2017-03, Vol.38 (2), p.262-276

2017

Volltextzugriff (PDF)

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study

Cancer medicine (Malden, MA), 2018-11, Vol.7 (11), p.5470-5477

2018

Volltextzugriff (PDF)

Trajectories of Injectable Cancer Drug Costs After Launch in the United States

Journal of clinical oncology, 2018-02, Vol.36 (4), p.319-325

2018

Volltextzugriff (PDF)

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

European urology, 2018-04, Vol.73 (4), p.628-634

2018

Volltextzugriff (PDF)

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2017-11, Vol.109 (11)

2017

Volltextzugriff (PDF)

Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study

Anticancer research, 2023-01, Vol.43 (1), p.239-245

2023

Volltextzugriff (PDF)

Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome

Medical science monitor, 2013-03, Vol.19, p.203-209

2013

Volltextzugriff (PDF)

Prospects of off-label (OL) drug use in oncology: Identifying predicting variables for registration and universal healthcare reimbursement

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18842-e18842

2021

Volltextzugriff (PDF)

Factors associated with off-label (OL) drug use in oncology: The role of cost and financing in a universal healthcare system

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18825-e18825

2021

Volltextzugriff (PDF)

The financial impact of fractionation scheme and treatment planning method for rectal cancer in the United States

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6518-6518

2019

Volltextzugriff (PDF)

Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors

Journal of the neurological sciences, 2021-08, Vol.427, p.117556, Article 117556

2021

Volltextzugriff (PDF)

Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study

Radiation oncology (London, England), 2012-08, Vol.7 (1), p.124-124, Article 124

2012

Volltextzugriff (PDF)

Price trajectory of individual cancer drugs following launch

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.6502-6502

2016

Volltextzugriff (PDF)

FDG-PET/CT in small cell lung cancer (SCLC): A value analysis

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.6626-6626

2016

Volltextzugriff (PDF)

The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial

Radiotherapy and oncology, 2019-05, Vol.134, p.74-80

2019

Volltextzugriff (PDF)

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience

Medicine (Baltimore), 2021-06, Vol.100 (25), p.e26388-e26388

2021

Volltextzugriff (PDF)

Next Generation Sequencing in Salivary Gland Carcinomas: Do Actionable Mutations Lead to a Therapeutic Advantage? A Multicenter Experience

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e17582-e17582

2019

Volltextzugriff (PDF)

A real-world analysis of cancer drug wastage due to oversized vials

Journal of the American Pharmacists Association, 2018-11, Vol.58 (6), p.643-646

2018

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(117)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(51)
Humans
(33)
Male
(23)
Animals
(22)
Female
(20)
Oncology
(19)
Middle Aged
(15)
Adult
(14)
Multidisciplinary Sciences
(13)
Science & Technology - Other Topics
(13)
Aged
(12)
Social Sciences
(12)
Patients
(11)
Psychology
(11)
Transplantation
(8)
Aged, 80 And Over
(7)
Biology
(7)
Formicidae
(7)
Rats
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer

Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Next‐generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage—Multicenter experience

Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer

Media representations of national and international standardized testing in the Israeli education system

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study

Trajectories of Injectable Cancer Drug Costs After Launch in the United States

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer

Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study

Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome

Prospects of off-label (OL) drug use in oncology: Identifying predicting variables for registration and universal healthcare reimbursement

Factors associated with off-label (OL) drug use in oncology: The role of cost and financing in a universal healthcare system

The financial impact of fractionation scheme and treatment planning method for rectal cancer in the United States

Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors

Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study

Price trajectory of individual cancer drugs following launch

FDG-PET/CT in small cell lung cancer (SCLC): A value analysis

The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience

Next Generation Sequencing in Salivary Gland Carcinomas: Do Actionable Mutations Lead to a Therapeutic Advantage? A Multicenter Experience

A real-world analysis of cancer drug wastage due to oversized vials

Suchergebnisse filtern